1. Home
  2. PRI vs BIO Comparison

PRI vs BIO Comparison

Compare PRI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primerica Inc.

PRI

Primerica Inc.

HOLD

Current Price

$281.05

Market Cap

8.5B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$287.98

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRI
BIO
Founded
1927
1952
Country
United States
United States
Employees
N/A
7450
Industry
Life Insurance
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
6.9B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
PRI
BIO
Price
$281.05
$287.98
Analyst Decision
Hold
Buy
Analyst Count
4
4
Target Price
$294.00
$339.75
AVG Volume (30 Days)
165.9K
430.6K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
1.72%
N/A
EPS Growth
67.10
N/A
EPS
5.97
N/A
Revenue
$3,291,713,000.00
N/A
Revenue This Year
$3.98
$2.74
Revenue Next Year
$5.08
$3.20
P/E Ratio
$46.97
$9.72
Revenue Growth
6.56
N/A
52 Week Low
$230.09
$211.43
52 Week High
$288.03
$343.12

Technical Indicators

Market Signals
Indicator
PRI
BIO
Relative Strength Index (RSI) 58.40 61.14
Support Level $266.27 $259.31
Resistance Level $287.39 $288.48
Average True Range (ATR) 7.45 8.98
MACD 0.14 4.66
Stochastic Oscillator 68.83 93.29

Price Performance

Historical Comparison
PRI
BIO

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: